I. Bjornaes et al., Measurement of the extracellular volume of human melanoma xenografts by contrast enhanced magnetic resonance imaging, MAGN RES IM, 18(1), 2000, pp. 41-48
The magnitude of the extracellular volume fraction (ECV) of tumors is of im
portance for the transport of macromolecular therapeutic agents from the ve
ssel wall to the tumor cells. The aim of this study was to develop a method
for measurement of tumor ECV by contrast enhanced MRI. Tumors of two human
amelanotic melanoma xenograft lines (A-07 and R-18) grown intradermally in
Balb/c nu/nu mice were used as model system, and muscle tissue was used as
control. The renal arteries of the mice were ligated prior to i.v. adminis
tration of Gd-DTPA, and an MRI protocol for calculating Gd-DTPA concentrati
on in tissue was followed. ECV was calculated from the Gd-DTPA concentratio
ns in the tissue and in a plasma sample. In muscle tissue, the concentratio
n reached a constant level after 1 min and the ECV was calculated to be 0.1
2 (+/- 0.01), consistent with values reported in the literature. Individual
tumors showed large differences in the uptake of Gd-DTPA. The Cd-DTPA conc
entration in the tissue at 40 min after the Gd-DTPA administration was used
to calculate tumor ECV. The ECV was found to differ significantly among re
gions of individual tumors and among individual tumors. The ECV ranged from
0.075 to 0.33 for A-07 tumors and from 0.016 to 0.097 for R-18 tumors. The
intra- and intertumor heterogeneity in ECV was confirmed by histologic fin
dings, showing that contrast enhanced MRI is suitable for non-invasive stud
ies of the ECV in experimental tumors without necrosis. (C) 2000 Elsevier S
cience Inc. All rights reserved.